| |
 |
|
Class Information
Number: 514/235.8
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) > Morpholines (i.e., fully hydrogenated 1,4- oxazines) > Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding > Ring nitrogen in the additional hetero ring > Plural ring nitrogens in the additional hetero ring (e.g., imidazole, pyrazine, etc.)
Description: Subject matter in which the additional hetero ring contains plural ring nitrogens.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6329371 |
.alpha.-substrates benzyl heterocyclic derivatives, intermediates for producing the same and agrochemical composition containing the same as active ingredient |
Dec. 11, 2001 |
| 6326371 |
Pyrudyl and pyrimidylpiperazine derivatives |
Dec. 4, 2001 |
| 6316444 |
SRC kinase inhibitor compounds |
Nov. 13, 2001 |
| 6316451 |
Heterocyclyl anthracyclinone derivatives |
Nov. 13, 2001 |
| 6313119 |
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
Nov. 6, 2001 |
| 6313118 |
Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
Nov. 6, 2001 |
| 6313120 |
N-(arylsulfonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
Nov. 6, 2001 |
| 6306860 |
2,5-pyridinedicarboxylic acid derivatives |
Oct. 23, 2001 |
| 6300356 |
Method for decreasing QT dispersion or inhibiting the progression of QT dispersion with an angiotensin II receptor antagonist |
Oct. 9, 2001 |
| 6297239 |
Inhibitors of prenyl-protein transferase |
Oct. 2, 2001 |
| 6294535 |
Uracil derivatives and antitumor effect potentiator and antitumor agent containing the same |
Sep. 25, 2001 |
| 6294542 |
Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
Sep. 25, 2001 |
| 6291457 |
Compounds having cytokine inhibitory activity |
Sep. 18, 2001 |
| 6291458 |
Morpholinobenzamide salts |
Sep. 18, 2001 |
| 6288061 |
Imidazole derivatives |
Sep. 11, 2001 |
| 6288060 |
Amino substituted pyrimidines and triazines |
Sep. 11, 2001 |
| 6281210 |
Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
Aug. 28, 2001 |
| 6274588 |
4-phenyl-pyrimidine derivatives |
Aug. 14, 2001 |
| 6271237 |
Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors |
Aug. 7, 2001 |
| 6271249 |
Diphenyl imidazoles as potassium channel modulators |
Aug. 7, 2001 |
| 6271229 |
Method of treating gastrointestinal motility disorders |
Aug. 7, 2001 |
| 6271230 |
Use of NK-1 receptor antagonists for treating cognitive disorders |
Aug. 7, 2001 |
| 6268363 |
Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof |
Jul. 31, 2001 |
| 6262052 |
Amino acid ester containing azole antifungals |
Jul. 17, 2001 |
| 6258817 |
Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof |
Jul. 10, 2001 |
| 6242446 |
Method for treating attention deficit disorder |
Jun. 5, 2001 |
| 6235760 |
Treatment for CNS injuries |
May. 22, 2001 |
| 6232311 |
Method for treating or preventing psychosomatic and psychoimmunologic disorders |
May. 15, 2001 |
| 6225309 |
Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
May. 1, 2001 |
| 6221858 |
Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders |
Apr. 24, 2001 |
| 6218376 |
Uracil compounds as P2-purinoreceptor 7-transmembrane G-protein coupled receptor antagonists |
Apr. 17, 2001 |
| 6207665 |
Piperazine derivatives and their use as anti-inflammatory agents |
Mar. 27, 2001 |
| 6204264 |
Benzimidazole derivative, hair growth promoter and external composition for skin using the same |
Mar. 20, 2001 |
| 6204265 |
Substituted oximes and hydrazones as neurokinin antagonists |
Mar. 20, 2001 |
| 6204268 |
Selective factor Xa inhibitors |
Mar. 20, 2001 |
| 6204263 |
Pyrazinone protease inhibitors |
Mar. 20, 2001 |
| 6201002 |
Method for reducing mortality with an angiotensin II antagonist |
Mar. 13, 2001 |
| 6194413 |
Hemoregulatory compounds |
Feb. 27, 2001 |
| 6180627 |
Antithrombotic agents |
Jan. 30, 2001 |
| 6180624 |
Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception |
Jan. 30, 2001 |
| 6177067 |
Hair revitalizing tonic composition containing a 2,2-dimethylpropanediol compound and use thereof |
Jan. 23, 2001 |
| 6172067 |
2-substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists |
Jan. 9, 2001 |
| 6159995 |
Substituted diaminocarboxylic acids |
Dec. 12, 2000 |
| 6159972 |
Combination of a selective 5-HT.sub.1A antagonist and a selective ub . h5-HT.s1B antagonist or partial agonist |
Dec. 12, 2000 |
| 6159971 |
Combination of a 5-HT reuptake inhibitor and a H5-HT1B anatagonist or partial agonist |
Dec. 12, 2000 |
| 6159970 |
Combination of a monoamine oxidase inhibitor and a h5-HT.sub.1B antagonist or partial agonist |
Dec. 12, 2000 |
| 6159969 |
Uracil derivatives, and antitumor effect potentiator and antitumor agent containing the same |
Dec. 12, 2000 |
| 6159980 |
Pyrazinones and triazinones and their derivatives thereof |
Dec. 12, 2000 |
| 6140330 |
Thiazole derivative |
Oct. 31, 2000 |
| 6140324 |
Use of a tachykinin antagonist and a muscarinic antagonist and/or an antihistamine to treat motion sickness |
Oct. 31, 2000 |
|
|
|
